Fluorescence Spectroscopy for Real-Time Intraoperative Detection of Middle-Ear Cholesteatoma.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41865269.
- Also identified by DOI 10.1002/ohn.70207.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To evaluate whether autofluorescence spectroscopy (AFS) can reliably distinguish cholesteatoma from surrounding middle-ear tissues, and to develop a real-time intraoperative diagnostic tool. Prospective ex vivo study. Besançon University Hospital, France (tertiary care center). In this prospective ex vivo study, middle-ear tissue biopsies were collected during cholesteatoma surgeries and analyzed using autofluorescence following 405-nm laser excitation. Each sample was classified based on its spectral signature and confirmed by histopathology. A computer-assisted model was applied to differentiate cholesteatoma from noncholesteatoma tissues, and its performance was assessed using standard cross-validation. Thirty-six tissue samples from 23 patients were analyzed, generating nearly 3800 fluorescence spectra. The model correctly classified all samples, achieving 94.5% accuracy, 94.7% sensitivity, and 94.2% specificity. The system provided consistent performance across tissue types and returned results in real time, with a response time of 0.1 seconds per sample. Each output included a probability score indicating the likelihood of cholesteatoma presence. AFS demonstrated high accuracy in distinguishing cholesteatoma from other middle-ear tissues. Its speed, simplicity, and probabilistic feedback suggest strong potential for real-time intraoperative use. Once validated in vivo, this technology could assist surgeons by improving tissue discrimination and potentially reducing recurrence rates.